The Recall Desk
Agency classClass IOur severity:SevereFDA (Devices)·Z-1372-2013·Announced 2013-06-05

AsthmaNefrin Starter Kit Recalled for Choking Hazard

Nephron Pharmaceuticals is recalling AsthmaNefrin Starter Kits because a component may dislodge and cause a choking hazard.

The agency’s classification

FDA (Devices): Class I

Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classified this recall as Class I — a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. On that classification alone this is scored Severe; a score of Critical is reserved for recalls where a death or serious injury was reported. The agency gives the reason as: "Possible dislodgement of the "Plate A", if this instance occurs, it presents a potential choking hazard."

Plain-English summary

Nephron Pharmaceuticals Corp. is recalling 241,538 AsthmaNefrin Starter Kits. Each kit contains ten AsthmaNefrin vials and one EZ Breathe Atomizer, which are used for the delivery of liquid medications for respiratory usage.

The recall is due to a potential choking hazard. The source text indicates that a component labeled "Plate A" may dislodge, presenting this risk. The affected lots are R2029A, R2029B, R2039A, R2042A, R2045A, and R2047A. Specific atomizer serial number ranges are also identified in the recall notice.

The products were distributed nationwide in the United States, including DC and Puerto Rico, as well as in Guatemala, Poland, Panama, and the United Kingdom. Consumers should stop using the affected products and contact the manufacturer for instructions.

The recalled product

Product
AsthmaNefrin Starter Kit contains ten (10) AsthmaNefrin vials and one (1) EZ Breathe Atomizer. For the delivery of liquid medications for respiratory usage.
Manufacturer
Nephron Pharmaceuticals Corp.
Category
Medical Device — Respiratory Delivery
Hazard
Affected units
241,538

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (5)

  • Lots # R2029A
  • R2029B
  • R2039A
  • R2042A
  • R2045A

Distribution

Distributed nationwide across the United States.

The notice also names 34 states specifically:

Part of a larger recall action

This product is one of 3 recalled by Nephron Pharmaceuticals Corp. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 3 products in this recall →

Related recalls

Same manufacturer · Nephron Pharmaceuticals Corp.

See all →

Same hazard · choking

See all →

Similar recalls